C3is (CISS) Competitors $2.09 -0.07 (-3.24%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$2.10 +0.01 (+0.48%) As of 09/5/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CISS vs. MODV, SGLY, SQZ, GVH, OP, USDP, AIRTP, BLDEW, RA, and EDRYShould you be buying C3is stock or one of its competitors? The main competitors of C3is include ModivCare (MODV), Singularity Future Technology (SGLY), SQZ Biotechnologies (SQZ), Globavend (GVH), OceanPal (OP), USD Partners (USDP), Air T (AIRTP), Blade Air Mobility (BLDEW), Brookfield Real Assets Income Fund (RA), and EuroDry (EDRY). These companies are all part of the "transportation" industry. C3is vs. Its Competitors ModivCare Singularity Future Technology SQZ Biotechnologies Globavend OceanPal USD Partners Air T Blade Air Mobility Brookfield Real Assets Income Fund EuroDry ModivCare (NASDAQ:MODV) and C3is (NASDAQ:CISS) are both small-cap transportation companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk. Which has stronger valuation & earnings, MODV or CISS? C3is has lower revenue, but higher earnings than ModivCare. C3is is trading at a lower price-to-earnings ratio than ModivCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioModivCare$2.75B0.00-$201.28M-$16.10-0.03C3is$36.42M0.05-$2.75M-$18.04-0.12 Does the media refer more to MODV or CISS? In the previous week, C3is had 6 more articles in the media than ModivCare. MarketBeat recorded 6 mentions for C3is and 0 mentions for ModivCare. C3is' average media sentiment score of 0.68 beat ModivCare's score of 0.00 indicating that C3is is being referred to more favorably in the news media. Company Overall Sentiment ModivCare Neutral C3is Positive Do analysts prefer MODV or CISS? ModivCare presently has a consensus target price of $8.38, indicating a potential upside of 1,799.09%. Given ModivCare's stronger consensus rating and higher probable upside, research analysts plainly believe ModivCare is more favorable than C3is.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ModivCare 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25C3is 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals have more ownership in MODV or CISS? 10.5% of C3is shares are held by institutional investors. 15.5% of ModivCare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is MODV or CISS more profitable? C3is has a net margin of 20.51% compared to ModivCare's net margin of -8.33%. ModivCare's return on equity of 13.64% beat C3is' return on equity.Company Net Margins Return on Equity Return on Assets ModivCare-8.33% 13.64% -1.19% C3is 20.51%5.41%4.07% Which has more volatility & risk, MODV or CISS? ModivCare has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, C3is has a beta of 1.7, indicating that its share price is 70% more volatile than the S&P 500. SummaryModivCare and C3is tied by winning 8 of the 16 factors compared between the two stocks. Get C3is News Delivered to You Automatically Sign up to receive the latest news and ratings for CISS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CISS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CISS vs. The Competition Export to ExcelMetricC3isTRANS IndustryTransportation SectorNASDAQ ExchangeMarket Cap$1.93M$2.56B$7.31B$9.92BDividend YieldN/A4.95%949.17%4.52%P/E Ratio-0.1210.9013.7626.13Price / Sales0.053.23440.70172.60Price / CashN/A4.547.9159.28Price / Book0.000.852.216.09Net Income-$2.75M$527.30M$571.12M$266.51M7 Day Performance-30.56%-0.39%0.61%0.45%1 Month Performance-38.71%1.17%3.90%5.05%1 Year Performance-87.22%-7.91%15.66%26.03% C3is Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CISSC3is0.7625 of 5 stars$2.09-3.2%N/A-87.2%$1.93M$36.42M-0.12N/AShort Interest ↓MODVModivCare3.1957 of 5 stars$0.44-23.6%$8.38+1,799.1%-98.6%$6.33M$2.75B-0.0323,675Gap DownSGLYSingularity Future Technology1.3075 of 5 stars$1.07-1.8%N/A-53.9%$4.58M$3.14M-1.2440Short Interest ↓SQZSQZ BiotechnologiesN/A$0.03flatN/AN/A$826K$18.16M-0.011,620GVHGlobavend1.3096 of 5 stars$4.38-26.3%$80.00+1,726.5%-97.2%$440K$16.54M0.007Positive NewsAnalyst DowngradeGap DownHigh Trading VolumeOPOceanPalN/A$1.15-11.5%N/A-96.9%$400K$25.70M-0.0260Positive NewsUpcoming EarningsShort Interest ↓USDPUSD PartnersN/A$0.01-1.2%N/A-70.5%$284K$72.32M-0.0190High Trading VolumeAIRTPAir TN/A$19.36+1.5%N/A+12.3%$0.00$296.31M0.00500Short Interest ↓BLDEWBlade Air MobilityN/A$0.18+7.1%N/A-9.0%$0.00$254.34M0.00130Short Interest ↓Gap DownRABrookfield Real Assets Income FundN/A$13.520.0%N/A+1.3%$0.00$67.52M-122.86N/AEDRYEuroDryN/A$10.99+0.8%N/A-45.6%$0.00$61.08M-2.11N/AGap UpHigh Trading Volume Related Companies and Tools Related Companies ModivCare Competitors Singularity Future Technology Competitors SQZ Biotechnologies Competitors Globavend Competitors OceanPal Competitors USD Partners Competitors Air T Competitors Blade Air Mobility Competitors Brookfield Real Assets Income Fund Competitors EuroDry Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CISS) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C3is Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share C3is With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
